Protalix BioTherapeutics, Inc. (PLX)
NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 10:00AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 94.58M |
| Enterprise Value | 72.46M |
| Trailing P/E | 16.12 |
| Forward P/E | 10.75 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.87 |
| Price/Book (mrq) | 3.18 |
| Enterprise Value/Revenue | 1.21 |
| Enterprise Value/EBITDA | 6.63 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.90 |
| 52-Week Change 3 | -38.28% |
| S&P500 52-Week Change 3 | 27.84% |
| 52 Week High 3 | 2.5100 |
| 52 Week Low 3 | 1.0300 |
| 50-Day Moving Average 3 | 1.2142 |
| 200-Day Moving Average 3 | 1.5194 |
Share Statistics
| Avg Vol (3 month) 3 | 433k |
| Avg Vol (10 day) 3 | 589.19k |
| Shares Outstanding 5 | 73.32M |
| Implied Shares Outstanding 6 | 73.32M |
| Float 8 | 54.52M |
| % Held by Insiders 1 | 14.58% |
| % Held by Institutions 1 | 13.00% |
| Shares Short (Apr 30, 2024) 4 | 6.99M |
| Short Ratio (Apr 30, 2024) 4 | 18.21 |
| Short % of Float (Apr 30, 2024) 4 | 9.97% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 9.53% |
| Shares Short (prior month Mar 28, 2024) 4 | 6.46M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Dec 20, 2019 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Dec 20, 2019 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 11.48% |
| Operating Margin (ttm) | -129.56% |
Management Effectiveness
| Return on Assets (ttm) | 6.45% |
| Return on Equity (ttm) | 44.48% |
Income Statement
| Revenue (ttm) | 59.65M |
| Revenue Per Share (ttm) | 0.83 |
| Quarterly Revenue Growth (yoy) | -60.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | 9.3M |
| Net Income Avi to Common (ttm) | 6.85M |
| Diluted EPS (ttm) | 0.0800 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 48.49M |
| Total Cash Per Share (mrq) | 0.66 |
| Total Debt (mrq) | 26.37M |
| Total Debt/Equity (mrq) | 88.54% |
| Current Ratio (mrq) | 1.38 |
| Book Value Per Share (mrq) | 0.41 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 5.87M |
| Levered Free Cash Flow (ttm) | 5.05M |
© 2024 Yahoo. All rights reserved.